Top Markets
Coin of the day
Oxurion N.V. Oxurion N.V.

Oxurion N.V.

OXUR
Rankning i aktier #39567
Headquartered in Leuven, Belgium, and established in 1991, Oxurion N.V. is a... Headquartered in Leuven, Belgium, and established in 1991, Oxurion N.V. is a biopharmaceutical firm focused on researching, developing, and bringing to market treatments for various ocular conditions worldwide. Its primary commercialized offering is JETREA, a medication used to address vitreomacular adhesion and vitreomacular traction. The company's development pipeline includes THR-149, a plasma kallikrein inhibitor currently undergoing Phase II clinical trials for diabetic macular edema (DME), and THR-687, an integrin antagonist also in Phase II trials for DME. Oxurion has forged strategic partnerships with Bicycle Therapeutics, INC Research, and Galapagos NV. The organization was formerly known as ThromboGenics NV before officially changing its name to Oxurion NV in September 2018.
Aktiekurs
$0.003084
Marknadsvärde
$434.03K
Förändring (1 dag)
-7.14%
Förändring (1 år)
-89.24%
Land
BE
Handel Oxurion N.V. (OXUR)

Kategori

Aktiekurshistorik för Oxurion N.V. (OXUR)
Högsta slutkurs: $0.00 den 2026-08-01

Lägsta slutkurs: $62.97K den 2006-07-01
Aktiekurshistorik för Oxurion N.V. från 2006 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) 5.23%
2025 -96.55%
2024 -97.10%
2023 -94.05%
2022 -99.22%
2021 -35.88%
2020 10.67%
2019 -29.09%
2018 -4.13%
2017 62.47%
2016 -25.93%
2015 -55.06%
2014 -66.50%
2013 -54.24%
2012 123.36%
2011 -17.09%
2010 25.57%
2009 132.05%
2008 -27.90%
2007 10.78%
2006 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$517.18 32.51%
US
$857.76 31.47%
NL
$737.68 8.00%
CH
$1.07K -6.40%
KR
$258.82 14.34%
BE